Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula

Clinical trial NCT00992485 · COMPLETED

Trial details

NCT number: NCT00992485
Sponsor: Anterogen Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Crohn's Fistula

Start date: 2008-11-01
Primary completion: 2009-09-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.